coporal, I think most have been paying attention and are aware that RONIN can sell of PS-targeting R&D for breadcrumbs and quick self profit on top of the profitable PPHM position RONIN already has. Only a shareholder since Q1/2017 for the bulk of their 5+% position.
Have you been paying attention? No matter who "wins" the science is being sold or licensed off.
Every 45Mil$ gives RONIN 1$ extra profit. Every Month DELAY reduces RONIN's yearly % profit rate as their money is LOCKED in PPHM. Activists as RONIN do not like that.
So rather a MIXED BoD where the 3 RONIN guys push for the SELL/LICENSING of PS-targeting and WHERE the 4 PPHM guys make sure the deal is DONE at the MAXIMAL REASONABLE price in SHAREHOLDERS INTEREST.
Actually the above was another ADVANTAGE of a MIX BoD formed by CEO King + 3 NEW PPHM and 3 NEW RONIN.
I am discovering new advantages of UNBALANCING the PPHM WHITE CARD VOTE by voting candidates in and withholding DP, ES and CJ.